Lilly Loses UK High Court Alimta Battle

Eli Lilly & Co. will continue to "vigorously defend" its Alimta (pemetrexed disodium) patents in the UK, France, Italy and Spain, it said, following a UK High Court ruling last week that will allow competitor Actavis to market a generic version of the cancer drug.